Related Experiment Video
Updated: Nov 12, 2025

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Psychomotor Slowing in Schizophrenia: Implications for Endophenotype and Biomarker Development
K Juston Osborne1, Sebastian Walther2, Stewart A Shankman1,3
1Northwestern University, Department of Psychology, Evanston, IL, USA.
Psychomotor slowing is a key feature of schizophrenia, appearing independently of medication. This finding may serve as a valuable biomarker for identifying at-risk individuals and tracking illness progression.
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Motor abnormalities, including psychomotor slowing, are core features of schizophrenia.
- These abnormalities are independent of drug treatment and linked to genetic vulnerability and illness pathophysiology.
- Psychomotor slowing is a consistent and robust finding in schizophrenia research.
Purpose of the Study:
- To review the history and neural underpinnings of psychomotor slowing in psychosis.
- To examine literature supporting psychomotor slowing as an endophenotype and biomarker for schizophrenia.
- To highlight the utility of psychomotor slowing in identifying at-risk individuals and monitoring illness course.
Main Methods:
- Literature review synthesizing evidence from diverse methodologies and research designs.
- Analysis of studies investigating psychomotor slowing in relation to genetic vulnerability, disease processes, and recovery.
- Examination of cognitive and motor execution deficits associated with psychomotor slowing.
Main Results:
- Psychomotor slowing reflects genetic vulnerability and is sensitive to schizophrenia's disease processes.
- Cognitive deficits, particularly in planning and response selection, are prominent in psychomotor slowing.
- Psychomotor slowing predicts transition in high-risk individuals and correlates with symptoms and recovery.
Conclusions:
- Psychomotor slowing is a promising endophenotype and biomarker for schizophrenia.
- It aids in identifying individuals at high risk for the disorder.
- It can be used to track illness progression and recovery in patients.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Psychological and Sociocultural Causes of Schizophrenia
Psychosis: Goals of Pharmacotherapy
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...

